Chloroquine for the 2019 Novel Coronavirus SARS-CoV-2

Overview

Journal Int J Antimicrob Agents

Specialties Infectious Diseases
Pharmacology

Date 2020 Feb 20

PMID 32070753

Citations 208

Authors

Philippe Colson

Jean-Marc Rolain

Didier Raoult

Affiliations

Soon will be listed here.

Citing Articles

Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus.

Adha S, Afifah N, Latarissa I, Iftinan G, Kusuma A, Febriyanti R Diabetes Metab Syndr Obes. 2025; 18():135-146.

PMID: 39840393 PMC: 11746946. DOI: 10.2147/DMSO.S498774.

Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.

Mia M, Howlader M, Akter F, Hossain M Clin Pathol. 2024; 17:2632010X241263054.

PMID: 39070952 PMC: 11282570. DOI: 10.1177/2632010X241263054.

Potential Therapeutic Options for COVID-19.

Zheng X, Li L Infect Microbes Dis. 2024; 2(3):89-95.

PMID: 38630098 PMC: 8529694. DOI: 10.1097/IM9.0000000000000033.

A narrative review on adverse drug reactions of COVID-19 treatments on the kidney.

Jahanshahi F, Jazayeri S, Eraghi M, Reis L, Hamidikia M, Amiri S Open Med (Wars). 2024; 19(1):20230867.

PMID: 38584847 PMC: 10996932. DOI: 10.1515/med-2023-0867.

Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID-19 recovered individuals: A systematic review and meta-analysis.

Fajar J, Ilmawan M, Mamada S, Mutiawati E, Husnah M, Yusuf H Narra J. 2024; 1(3):e48.

PMID: 38450213 PMC: 10914045. DOI: 10.52225/narra.v1i3.48.

References

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Yu I, Qiu H, Tse L, Wong T . Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy. Clin Infect Dis. 2013; 58(5):683-6. PMC: 7108083. DOI: 10.1093/cid/cit797. View

White N, Pukrittayakamee S, Hien T, Faiz M, Mokuolu O, Dondorp A . Malaria. Lancet. 2013; 383(9918):723-35. DOI: 10.1016/S0140-6736(13)60024-0. View

Lee S, Silverman E, Bargman J . The role of antimalarial agents in the treatment of SLE and lupus nephritis. Nat Rev Nephrol. 2011; 7(12):718-29. DOI: 10.1038/nrneph.2011.150. View

Rolain J, Colson P, Raoult D . Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents. 2007; 30(4):297-308. PMC: 7126847. DOI: 10.1016/j.ijantimicag.2007.05.015. View

Agostini M, Andres E, Sims A, Graham R, Sheahan T, Lu X . Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio. 2018; 9(2). PMC: 5844999. DOI: 10.1128/mBio.00221-18. View

de Wilde A, Jochmans D, Posthuma C, Zevenhoven-Dobbe J, van Nieuwkoop S, Bestebroer T . Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014; 58(8):4875-84. PMC: 4136071. DOI: 10.1128/AAC.03011-14. View

Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M . In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004; 323(1):264-8. PMC: 7092815. DOI: 10.1016/j.bbrc.2004.08.085. View

Balzarini J, Keyaerts E, Vijgen L, Egberink H, De Clercq E, Van Ranst M . Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics. Antiviral Res. 2006; 72(1):20-33. PMC: 7114212. DOI: 10.1016/j.antiviral.2006.03.005. View

10.

Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A . New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006; 6(2):67-9. PMC: 7129107. DOI: 10.1016/S1473-3099(06)70361-9. View

11.

Al-Bari M . Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 2015; 70(6):1608-21. PMC: 7537707. DOI: 10.1093/jac/dkv018. View

12.

Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1953-66. DOI: 10.1056/NEJMoa030781. View

13.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

14.

Barnard D, Day C, Bailey K, Heiner M, Montgomery R, Lauridsen L . Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice. Antivir Chem Chemother. 2006; 17(5):275-84. DOI: 10.1177/095632020601700505. View

15.

Vincent M, Bergeron E, Benjannet S, Erickson B, Rollin P, Ksiazek T . Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005; 2:69. PMC: 1232869. DOI: 10.1186/1743-422X-2-69. View

16.

Mullard A . Drug repurposing programmes get lift off. Nat Rev Drug Discov. 2012; 11(7):505-6. DOI: 10.1038/nrd3776. View